Selection of In Vivo Relevant Dissolution Test Parameters for the Development of Cannabidiol Formulations with Enhanced Oral Bioavailability
<b>Background:</b> Cannabidiol (CBD) shows interesting therapeutic properties but has yet to demonstrate its full potential in clinical trials partly due to its low solubility in physiologic media. Two different formulations of CBD (amorphous and lipid-based) have been optimized and enab...
Saved in:
| Main Authors: | Nathan Koch, Quentin Bourcy, Olivier Jennotte, Patrice Chiap, Anna Lechanteur, Jean-Michel Cardot, Brigitte Evrard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/1/79 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DISSOLUTION MEDIA USED IN DEVELOPMENT AND QUALITY CONTROL OF DRUGS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01) -
Formulation and Evaluation of Solid Self-Nanoemulsifying Drug Delivery System of Cannabidiol for Enhanced Solubility and Bioavailability
by: Fengying Wu, et al.
Published: (2025-03-01) -
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)
by: Edward Chesney, et al.
Published: (2024-12-01) -
Pharmacokinetics of Cannabidiol in Rat Brain Tissue After Single-Dose Administration of Different Formulations
by: Zuzana Binova, et al.
Published: (2025-06-01) -
Development and Characterization of Optimized Drug-Loaded Niosomes for Delivery of 5-FU and Irinotecan
by: Kafilat O. Agbaje, et al.
Published: (2025-07-01)